OUR PROGRAMS 事業案内

OUR PROGRAMS

事業案内

Stealth RNA vector (SRV) innovations show
their power in various fields.

Improve Japanese medical competitiveness with stealth RNA vectors.
Using the world's only one gene expression vector, SRV, that enables persistent expression in the cytoplasm,
TOKIWA-Bio is going to develop safety gene therapy vectors from Japan.
SRV will produce both safe iPS cell production and direct reprogramming technology
to realize the industrialization of regenerative medicine.
SRV will contribute to the Japanese pharmaceutical industry through the production of high-quality biopharmaceuticals
such as vaccines and antibody drugs.